Cambridge Trust’s Insmed INSM Stock Holding History

Cambridge Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-250	Closed	-$7.75K	–	688
2023 Q4	$7.75K	Buy	+250	New	+$6.48K	﹤0.01%	600

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cambridge Trust's INSM Position: Q1 2024 in Review

Cambridge Trust sold out of Insmed (INSM) in Q1 2024, closing a stake of 250 shares — an estimated $7.75K sold.

Cambridge Trust first reported a position in INSM in Q4 2023 and held it in 1 quarter. The position peaked at $7.75K in Q4 2023. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.

Cambridge Trust reported no remaining Insmed position as of Q1 2024 after selling out during the quarter.
Cambridge Trust sold 250 Insmed shares in Q1 2024, an estimated $7.75K.
Cambridge Trust first reported a position in Insmed in Q4 2023 and held it in 1 quarter.
Cambridge Trust's Insmed position peaked at $7.75K in Q4 2023.
288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.